Integrative Neural Therapeutic Approach for Migraine with Aura – A Case Report

Abstract

This  case  report presents  the  clinical  course of  a  37-year-old  female  patient  diagnosed  with  migraine with  aura,  who  experienced  significant  and  sustained  symptom  relief following  neural  therapeutic interventions. The patient had a long-standing history of recurrent, unilateral, pulsating headaches, often preceded  by  visual  aura  symptoms  such  as scintillating  scotoma,  and  accompanied  by  nausea, photophobia,  and  phonophobia.  Previous  pharmacological  treatments  provided  only  limited  and temporary relief and were associated with side effects.

A structured, integrative therapeutic protocol was initiated, comprising neural therapy with 1% procaine administered segmentally at cervical ganglia (C2/C3), the stellate ganglion, tonsillar region, trigeminal pathways, and relevant vegetative-reflex zones. The treatment focused on modulation of the autonomic nervous  system  and  regulation  of  possible interference  fields.  After  just  two  sessions,  the  patient reported a marked reduction in attack frequency and improvement in vegetative symptoms, with further improvement following a total of four sessions. Complementary interventions included a migraine diary to  identify  individual  triggers,  nutritional  optimization,  stress  reduction,  and  patient  education  to improve early aura recognition and preventive action. Notably, the patient was able to discontinue acute medication use without recurrence of intense episodes, and her quality of life improved substantially.

This  case  underscores  the  value of  neural  therapy  as  a  safe, efficient,  and  individualized  approach in managing migraine with aura. The observed therapeutic effects are attributed to autonomic regulation, stabilization  of  neuroimmunological  networks,  and  treatment  of  interference  fields  such  as  chronic tonsillitis. Importantly, neural therapy allowed for medication sparing and enhanced patient compliance without systemic adverse effects. These findings support the integration of neural therapy into a holistic, patient-centered strategy  for  chronic  migraine  conditions.  It  provides  an  alternative  for  patients  who seek non-pharmacological treatment options and demonstrates promising potential in reducing migraine burden long-term.

Full article / DOI: https://doi.org/10.36266/JPDRM/145